Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer.
about
The Emerging Role of PD-1/PD-L1-Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Atezolizumab in urothelial bladder carcinoma.Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls.
P2860
Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Spotlight on atezolizumab and ...... ced urothelial bladder cancer.
@en
Spotlight on atezolizumab and ...... ced urothelial bladder cancer.
@nl
type
label
Spotlight on atezolizumab and ...... ced urothelial bladder cancer.
@en
Spotlight on atezolizumab and ...... ced urothelial bladder cancer.
@nl
prefLabel
Spotlight on atezolizumab and ...... ced urothelial bladder cancer.
@en
Spotlight on atezolizumab and ...... ced urothelial bladder cancer.
@nl
P2093
P2860
P356
P1476
Spotlight on atezolizumab and ...... ced urothelial bladder cancer.
@en
P2093
Aditya Bagrodia
Ahmet Murat Aydin
Martin Boegemann
Ryan C Hutchinson
Solomon L Woldu
Vitaly Margulis
P2860
P304
P356
10.2147/OTT.S109453
P407
P577
2017-03-09T00:00:00Z